IGF2 and breast cancer: Given that TNBC remains the most aggressive breast cancer subtype with the poorest prognosis (30), we chose two additional TNBC cell lines, MDA-MB-468 (MM468) and HCC1937, to confirm the broader significance of IGF-II–driven invasion.